Stealth BioTherapeutics

Stealth BioTherapeutics is a biopharmaceutical company headquartered in Needham, Massachusetts. The company employs 66 people and generates $12.8 million in annual revenue. Stealth BioTherapeutics focuses its efforts on developing innovative therapies to address mitochondrial dysfunction. Mitochondrial dysfunction is a key factor in both rare genetic diseases and common ailments associated with aging. Stealth BioTherapeutics is dedicated to creating targeted therapies that specifically address mitochondrial dysfunction. The company collaborates with leading academic institutions, medical professionals, and industry experts to advance its research and development efforts. Their pipeline includes both late-stage clinical programs and promising novel candidates. Stealth BioTherapeutics emphasizes its commitment to patient well-being. The company actively engages with patients and advocacy groups to gain a deeper understanding of their needs and raise awareness about the challenges posed by mitochondrial dysfunction. For inquiries or to explore career opportunities at Stealth BioTherapeutics, please visit their website at stealthbt.com.